Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma

Completed · Phase 2

Conditions studied: Low-Grade Lymphoma

In brief

Current therapies for Low-grade Non-Hodgkin's Lymphoma provide limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Low-grade Non-Hodgkin's Lymphoma. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with Low-grade Non-Hodgkin's Lymphoma.

Key facts

Study ID

NCT00003499

Run by

Burzynski Research Institute

People needed

31

Starts

1996-03-06

Expected to finish

2003-09-13

Last updated by the study team

2020-11-24

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Burzynski Clinic — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.